As a national-level high-tech enterprise, nuMVC specializes in research, development, production, and sales of advanced medical devices. The company is committed to providing innovative clinical solutions for the treatment of vascular diseases. With a focus on independent innovation, nuMVC has obtained multiple patents for its next-generation drug-eluting stent technology and drug-eluting balloon catheters.

These cutting-edge products have filled a gap in the domestic market and gained recognition as leaders in the field of coronary drug-eluting balloon catheters, particularly in the treatment of primary bifurcation lesions. nuMVC's product range includes the innovative vessel scaffolding system, drug-eluting stent systems, metal scaffold systems, PTCA balloon dilatation catheters, and imaging catheters. These products are known for their safety, efficacy, and ease of use, ensuring optimal patient outcomes.

Driven by a mission to create a homegrown brand for the Chinese people, nuMVC is dedicated to the development of the national healthcare industry. As a trusted brand, nuMVC combines expertise, quality, and innovation to deliver comprehensive solutions for vascular intervention